The anti-catabolic efficacy of insulin-like growth factor-I is enhanced by its early administration to rats receiving dexamethasone

Journal of Endocrinology

Volumn 157, Issue 1, 1998, Pages 89-97

  Tomas, F M ^a  

^a Div of Hlth Sciences and Nutrition   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATABOLISM; CATABOLITE REPRESSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; FOOD INTAKE; HORMONE RESPONSE; NITROGEN BALANCE; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

AGING; ANIMALS; BODY WEIGHT; DEXAMETHASONE; FEMALE; GROWTH; GROWTH SUBSTANCES; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NITROGEN; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0031967414     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1570089     Document Type: Article

References (30)

1. Batstone GF, Alberti KG, Hinks L, Smythe P, Laing JE, Ward CM, Ely DW & Bloom SR 1975 Metabolic studies in subjects following thermal injury. Intermediary metabolites, hormones and tissue oxygenation. Burns 2 207-225.
2. Butterfield GE, Thompson J, Rennie MJ, Marcus R, Hintz RL & Hoffman AR 1997 Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women. American Journal of Physiology 272 E94-E99.
3. Cheek DB, Powell GK & Scott RE 1965 Growth of muscle mass and skeletal collagen in the rat. I. Normal growth. Bulletin of the Johns Hopkins Hospital 116 378-387.
4. Chinn KSK & Hannon JP 1966 Relationship of muscle protein to other components of the fat free mass. American Journal of Physiology 211 993-997.
5. Cuthbertson DP 1964 Physical injury and its effects on protein metabolism. In Mammalian Protein Metaholism, vol 2, pp 373-114. Eds HN Munro & JB Allison. New York: Academic Press.
6. Douglas RG, Gluckman PD, Breier BH, McCall JL, Parry B & Shaw JH 1991 Effects of recombinant IGF-I on protein and glucose metabolism in rTNF-infused lambs. American Journal of Physiology 261 E606-E612.
7. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeill KA, Wallace JC, King R & Wells JRE 1992 Novel recombinant fusion protein variants of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology 8 213-223.
8. 3H]phenylalanine. Biochemical Journal 192 719-723.
9. Hizuka N, Takano K, Shizume K, Asakawa K, Miyakawa M, Tanaka I & Horikawa R 1986 Insulin-like growth factor-I stimulates growth in normal growing rats. European Journal of Pharmacology 125 143-146.
10. Jabri N, Schalch DS, Schwanz SL, Fischer JS, Kipnes MS, Radnik BJ, Turman NJ, Marcsisin VS & Guler H-P. 1994 Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type-II diabetic patients. Diabetes 43 369-374.
11. Kinney JM 1976 Surgical hypcrmetabolism and nitrogen metabolism. In Metabolism and the Response to Injury, pp 237-252. Eds AW Wilkinson & D Cuthbertson. Tunbridge Wells: Pitman Medical.
12. Kinney JM & Elwyn DH 1983 Protein metabolism and injury. Annual Review of Nutrition 3 433-466.
13. Lo HC, Hinton PS, Yang H, Unterman TG & Ney DM 1996 Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally ted rats. Journal of Parenteral and Enteral Nutrition 20 171-177.
14. Lord AD, Bastian SEP, Read LC, Walton PE & Ballard FJ 1994 Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. Journal of Endocrinology 140 475-182.
15. Mauras N & Beaufrere B 1995 Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminished the protein catabolic effects ot predmsone in humans without a diabetogenic effect. Journal of Clinical Endocrinology and Metabolism 80 869-874.
16. Miller SA 1969 Protein metabolism during growth and development. In Mammalian Protein Metabolism, vol 3, pp 183-233. Eds HN Munro & JB Allison. New York: Academic Press.
17. Miller SB, Martin DR, Kissane J & Hammerman MR 1994 Rat models for clinical use of insulin-like growth factor I in acute renal failure. American Journal of Physiology 266 F949-F956.
18. Munro HN & Fleck A 1969 Analysis of tissues and body fluids for nitrogenous constituents. In Mammalian Protein Metabolism, vol 3, pp 423-525. Eds HN Munro & JB Allison. New York: Academic Press.
19. Oehri M, Ninnis R, Girard J, Frey FJ & Keller U 1996 Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. American Journal of Physiology 270 E552-E558.
20. Ogawa I, Breier BH, Bauer MK, Gallaher BW, Grant PA, Walton PE, Owens JA & Gluckman PD 1996 Early treatment with bovine growth hormone is as effective as treatment during metabolic stress to reduce catabolism in fasted lambs. Endocrinology 137 1242-1248.
21. Reeds PJ 1992 Isotopic estimation of protein synthesis and proteolysis in vivo. In Modern Methods in Protein Nutrition and Metabolism, pp 249-273. Ed S Nissen. San Diego: Academic Press.
22. Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Gihron L & Hoffman AR 1995 The effects of recombinant human insulin like growth factor-I and growth hormone on body composition in elderly women. Journal of Clinical Endocrinology and Metabolism 80 1845-1852.
23. Tomas FM & Ballard FJ 1987 Applications of the 3-methylhistidine technique for measuring myofibrillar protein breakdown in vivo. In Lysasomes: Their Role in Protein Breakdown, pp. 679-711. Eds H Glaumann & FJ Ballard. London: Academic Press.
24. Tomas FM, Murray AJ & Jones LM 1984 Modification of glucocorticoid-induced changes in niyofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion of Nτ-mcthylhistidine. British Journal of Nutrition 51 323-337.
25. Tomas FM, Chandler CS, Knowles SE & Ballard FJ 1991 Reversal of dexamethasone-induced catabolism in rats by insulin-like growth factor-I (IGF-I) and especially des(1-3)IGF-I. Proceedings of the Nutrition Society of Australia 16 135.
26. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read I LC & Ballard FJ 1992 Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochemical Journal 282 91-97.
27. Tomas FM, Chandler CS, Knowles SE, Francis GL, Martin AA, Lemmey AB, Read LC & Ballard FJ 1993a Muscle protein turnover and IGF-I: anticatabolic and anabolic effects of IGFs. In Proteolysis and Protein Turnover, pp 141-148. Eds AJ Barrett & JS Bond. London: Portland Press.
28. Tomas FM, Knowles SE, Chandler CS, Francis GL, Owens PC & Bollard FJ 1993b Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. Journal of Endocrinology 137 413-421.
29. Ward MWN, Halliday D, Matthews DE, Matthews SM, Peters JL, Harrison RA, Clark CG & Rennie MJ 1983 The effect of enteral nutritional support on skeletal muscle protein synthesis and whole-body protein turnover in fasted surgical patients. Human Nutrition: Clinical Nutrition 37C 453-458.
30. Ziegler TR, Gatsen C & Wilmore DW 1994 Strategies for attenuating protein catabolic responses in the critically ill. Annual Reviws of Medicine 45 459-480.